Retraction notice to "MiR-539 inhibits human colorectal cancer progression by targeting RUNX2â³ [Biomed. Pharmacother. 95 (2017) 1314-1320].

Wen, Dacheng; Li, Songhe; Jiang, Weidong; Zhu, Jiaming; Liu, Jingjing; Zhao, Shutao

Retraction notice to "MiR-539 inhibits human colorectal cancer progression by targeting RUNX2â³ [Biomed. Pharmacother. 95 (2017) 1314-1320].

Wen, Dacheng; Li, Songhe; Jiang, Weidong; Zhu, Jiaming; Liu, Jingjing; Zhao, Shutao.

Afiliação

Wen D; Department of Gastrointestinal nutrition and hernia surgery, the Second Hospital of Jilin University, Nanguan District, Changchun 130041, China.
Li S; Department of Ophthalmology, the First Hospital of Jilin University, Chaoyang District, Changchun 130021, China.
Jiang W; Department of Hepatobiliary and Pancreatic Surgery, the Second Hospital of Jilin University, Nanguan District, Changchun 130041, China.
Zhu J; Department of Gastrointestinal nutrition and hernia surgery, the Second Hospital of Jilin University, Nanguan District, Changchun 130041, China.
Liu J; Department of Gastrointestinal nutrition and hernia surgery, the Second Hospital of Jilin University, Nanguan District, Changchun 130041, China.
Zhao S; Department of Gastrointestinal nutrition and hernia surgery, the Second Hospital of Jilin University, Nanguan District, Changchun 130041, China.

Biomed Pharmacother ; 167: 115375, 2023 11.

Article em En | MEDLINE | ID: mdl-37802728

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article